Merus N.V. Announces Proposed Public Offering of Common Shares

UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 28, 2024 -- Merus N.V. , a clinical-stage oncology company developing innovative, full-length multispecific antibodies , today announced the...

Related Keywords

Boston ,Massachusetts ,United States ,Ukraine ,Netherlands ,United Kingdom ,Cambridge ,Cambridgeshire ,New York ,Van Lanschot Kempen ,Leerink Partners ,European Union Withdrawal ,Financial Conduct Authority ,Financial Services ,Guggenheim Securities ,Syndicate Department ,Equity Syndicate Prospectus Department ,Capital Markets Corp ,Exchange Commission ,Prospectus Department ,Equity Syndicate Department ,Offer Shares ,Bofa Securities ,Lanschot Kempen ,European Economic Area ,Prospectus Regulation ,European Union ,Kingdom Prospectus ,Tryon Street ,Markets Corp ,United Kingdom Prospectus ,Relevant State ,United Kingdom Prospectus Regulation ,Markets Act ,Financial Promotion ,Private Securities Litigation Reform Act ,Russia Ukraine ,Middle East ,Quarterly Report ,